Dysesthesia signal (Phase 3) TRIUMPH-4 topline results, released December 11, 2025, reported dysesthesia in about 20.9% of participants at the highest dose
Nutrition research (New York, N.Y.) 2020
Rather than seeing recent legal and FDA actions as roadblocks, leading companies are using this moment to rebuild smarter, partner stronger, and scale more sustainably
The over the counter drug is used by millions across the world, and increasingly by pregnant women (up to 65%)
Those with digestive disorders should be particularly cautious, as many commercial detox formulas contain stimulant laxatives that can worsen symptoms and cause dangerous electrolyte imbalances with prolonged use
The review also received funding from the Surface Nature Foundation which is undertaken by the Second Affiliated Hospital of Shanxi Medical University